Droperidol
Modify Date: 2025-08-21 10:00:43
Droperidol structure
|
Common Name | Droperidol | ||
|---|---|---|---|---|
| CAS Number | 548-73-2 | Molecular Weight | 379.427 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 616.4±65.0 °C at 760 mmHg | |
| Molecular Formula | C22H22FN3O2 | Melting Point | 148-149ºC | |
| MSDS | Chinese USA | Flash Point | 326.6±34.3 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of DroperidolDroperidol is a Dopamine-2 Receptor Antagonist. Target: D2DRDroperidol is a butyrophenone, with anti-emetic, sedative and anti-anxiety properties. |
| Name | droperidol |
|---|---|
| Synonym | More Synonyms |
| Description | Droperidol is a Dopamine-2 Receptor Antagonist. Target: D2DRDroperidol is a butyrophenone, with anti-emetic, sedative and anti-anxiety properties. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 616.4±65.0 °C at 760 mmHg |
| Melting Point | 148-149ºC |
| Molecular Formula | C22H22FN3O2 |
| Molecular Weight | 379.427 |
| Flash Point | 326.6±34.3 °C |
| Exact Mass | 379.169617 |
| PSA | 58.10000 |
| LogP | 4.22 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.636 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | 36 |
| RIDADR | UN 3249 |
| WGK Germany | 3 |
| RTECS | DE2100000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
|
~%
Droperidol CAS#:548-73-2 |
| Literature: US3936468 A1, ; |
![1-(p-Fluorophenyl)-4-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-1-butanol structure](https://image.chemsrc.com/caspic/230/60373-72-0.png)
| Precursor 1 | |
|---|---|
| DownStream 0 | |
|
Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014) • The introduction has been modified. • More references have been added to the text. • Limitations of the method have been discussed more in detail. |
|
|
Function-triggering antibodies to the adhesion molecule L1 enhance recovery after injury of the adult mouse femoral nerve.
PLoS ONE 9(11) , e112984, (2014) L1 is among the few adhesion molecules that favors repair after trauma in the adult central nervous system of vertebrates by promoting neuritogenesis and neuronal survival, among other beneficial feat... |
|
|
Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
J. Phys. Chem. B 118(33) , 9974-82, (2014) Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly i... |
| 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one |
| 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
| 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro- |
| 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl}-2,3-dihydro-1H-benzimidazol-2-one |
| 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro- |
| Halkan |
| 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-1,3-dihydro-2H-benzimidazol-2-one |
| Dridol |
| Sintosian |
| 1-(4-Fluorophenyl)-4-[4-(2-hydroxy-1H-benzimidazol-1-yl)-3,6-dihydro-1(2H)-pyridinyl]-1-butanone |
| 1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one |
| MFCD00083290 |
| EINECS 208-957-8 |
| 1-{1-[4-(4-Fluorphenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-on |
| Dehydrobenzperidol |
| Sintodril |
| Properidol |
| INAPSINE |
| 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-benzimidazol-1-yl)-3,6-dihydropyridin-1(2H)-yl]butan-1-one |
| 1-butanone, 4-[3,6-dihydro-4-(2-hydroxy-1H-benzimidazol-1-yl)-1(2H)-pyridinyl]-1-(4-fluorophenyl)- |
| Droleptan |
| Droperidol |
| 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl}-1,3-dihydro-2H-benzimidazol-2-one |
| Innovar |